CEO Perspectives On The Different Methods Of Going Public
Source: Life Science Leader
In this executive virtual roundtable (EVR) segment, an audience question asks for perspectives on the different methods of taking a company public. Roger Crystal, M.D., CEO of Opiant Pharmaceuticals; Ivana Magovcevic-Liebisch, Ph.D., J.D., CEO of Vigil Neuroscience; and Frank Lee, CEO of Forma Therapeutics, weigh in.
View the full presentation here.
This website uses cookies to ensure you get the best experience on our website. Learn more